Decades-old national estimates indicate that only 2%-3% of adults with cancer participate in clinical trials. However, these outdated estimates focus on patient enrollment in treatment trials only.
The researchers assessed annual enrollment in a variety of study types, including those focused on treatments, diagnostics, economic, genetics, prevention, quality of life, and registry data, between 2013 and 2017. The researchers estimated that 7.1% of adults with cancer participated in treatment trials between 2013 and 2017, more than two times higher than the historical estimates of 2%-3%.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AI's Impact On Patient Care, Clinical Coding And Quality MetricsDavid Lareau is CEO of Medicomp Systems, which makes medical data relevant, usable and actionable. Read David Lareau's full executive profile here.
Source: ForbesTech - 🏆 318. / 59 Read more »
Baylor Scott & White clinical trial brings new hope to Arlington man, who's now cancer free'We celebrate our wins,' said Kenny Keown. 'I've been blessed through this process,' he said of a Baylor Scott & White Health clinical trial.
Source: wfaa - 🏆 543. / 51 Read more »
Study Finds Limited Clinical Benefit for Cancer Drugs Approved Under FDA's Accelerated Approval PathwayA new study reveals that less than half of the cancer drugs approved under the FDA's accelerated approval pathway have been shown to improve overall survival or quality of life, despite being on the market for more than 5 years.
Source: Medscape - 🏆 386. / 55 Read more »
Contributions of People with Cancer in Clinical ResearchClinical research, in all of its forms, simply cannot be conducted without the contributions of people with cancer. These contributions are much more extensive than was previously recognized. The expanded analysis included more than 70% of people diagnosed with cancer each year in the United States. Participation in treatment trials was more than five-fold higher at National Cancer Institute-designated cancer centers than at community hospitals.
Source: MedicineNet - 🏆 575. / 51 Read more »
New Clinical Trials in Prostate Cancer: Investigating the Efficacy of SaruparibSeveral new clinical trials in prostate cancer have started recruiting in recent months. One of the trials is examining the efficacy of an experimental PARP inhibitor called saruparib when added to a next-generation hormonal agent. This article provides an overview of the study and its potential benefits for patients.
Source: Medscape - 🏆 386. / 55 Read more »